Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Absorption, metabolism, and excretion of salicylazosulfapyridine in man.

× No keyword cloud information.

81 in total

Review 1. Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors: D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal: Clin Pharmacokinet Date: 1999-03 Impact factor: 6.447

Review 2. Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors: L A Pagliaro; L Z Benet
Journal: J Pharmacokinet Biopharm Date: 1975-10

Review 3. Drug therapy of ulcerative colitis.

Authors: B Crotty; D P Jewell
Journal: Br J Clin Pharmacol Date: 1992-09 Impact factor: 4.335

4. Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions.

Authors: R A van Hogezand; H M Kennis; A van Schaik; J P Koopman; P A van Hees; J H van Tongeren
Journal: Eur J Clin Pharmacol Date: 1992 Impact factor: 2.953

Review 5. Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors: Michael T Nurmohamed; Ben A C Dijkmans
Journal: Drugs Date: 2005 Impact factor: 9.546

Review 6. Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid.

Authors: U Klotz
Journal: Clin Pharmacokinet Date: 1985 Jul-Aug Impact factor: 6.447

7. Fucosylated multiwalled carbon nanotubes for Kupffer cells targeting for the treatment of cytokine-induced liver damage.

Authors: Richa Gupta; Neelesh Kumar Mehra; Narendra Kumar Jain
Journal: Pharm Res Date: 2013-09-17 Impact factor: 4.200

8. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

Authors: A K Azadkhan; S C Truelove; J K Aronson
Journal: Br J Clin Pharmacol Date: 1982-04 Impact factor: 4.335

9. The metabolism of salicylazosulphapyridine in ulcerative colitis: II The relationship between metabolites and the progress of the disease studied in outpatients.

Authors:
Journal: Gut Date: 1973-08 Impact factor: 23.059

10. Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial.

Authors: K R Palmer; J R Goepel; C D Holdsworth
Journal: Br Med J (Clin Res Ed) Date: 1981-05-16